Navigation Links
Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signals
Date:4/22/2009

This release is available in Chinese.

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the efficacy of the Opioid Growth Factor (OGF, [Met5]-enkephalin), a clinically important antitumor agent, is dependent on nucleocytoplasmic translocation and reliant on the integrity of nuclear localization signals in the OGF receptor (OGFr). This discovery, reported in the May 09 issue of Experimental Biology and Medicine, provides new insights into the mechanism of an important endogenous system that serves as a tonically active, constitutively expressed, inhibitory regulator of DNA synthesis. This valuable information not only may contribute to understanding the etiology and pathogenesis of diseases related to this native biological system, but to the development of new agents that will enhance effectiveness in treatment.

Previous immunohistochemical and immunoelectron microscope studies have detected OGF and OGFr in both the cytoplasmic and the nuclear compartments. The OGF-OGFr axis is known to regulate cell proliferation by modulating cyclin dependent kinase inhibitors, resulting in a retardation of cells at the G1-S interface of the cell cycle. To address the question of the location and temporal relationships of OGFr nucleocytoplasmic trafficking, a probe of OGFr fused to green fluorescent protein (eGFP) was constructed. Experiments with a human cancer cell, a squamous cell carcinoma of the head and neck, revealed that translation of OGFr required approximately 5 hours, and transit into the nucleus took 8 hours; OGFr remained in the nucleus for up to 8 days. Transport through the nuclear pore and repression of cell proliferation required two of the three nuclear localization signals (NLS) in OGFr. These results show that the pathway for regulating the cell cycle by the O
'/>"/>

Contact: Dr. Ian S. Zagon
isz1@psu.edu
717-531-6409
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A paradigm shift in immune response regulation
2. Unclear regulations obstacle to biological diversity
3. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
4. Scientists shed light on evolution of gene regulation
5. Conaway Lab identifies novel mechanism for regulation of gene expression
6. CU-Boulder study suggests air quality regulations miss key pollutants
7. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
8. New insights into the regulation of PTEN tumor suppression function
9. New regulations tighten controls on restricted chemicals
10. Systems biology approach identifies nutrient regulation of biological clock in plants
11. Epigenetic regulation by the MMB/dREAM complex

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Center and the Chinese Academy of Sciences (CAS) ...on Taste and Smell Research. Organized by Monell i...the first international meeting on taste and smell...utive Officer, American Association for the Advanc...e magazine, will open the meeting with a plenary a...
(Date:11/4/2009)...ant to officially endorse green tea as a cancer pr...its protective effects, including results of a new...a journal of the American Association for Cancer R...cer. , Vassiliki Papadimitrakopoulo, M.D., prof...ad and Neck Medical Oncology at the University of ...
(Date:11/4/2009)..., hold the power to help militaries and munitions ...ic waste on test sites. , Compounds known as nit...orld War II and have been used in military munitio...ften used to propel tank shells and act like a mor...d knowledge of their environmentally harmful effec...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2IMRIS receives FDA clearance for IMRISNV and IMRIScardio 56403 1IMRIS receives FDA clearance for IMRISNV and IMRIScardio 56403 2Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 1Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 2Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 3Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 4New York Giants to Host American Red Cross Blood Drive 56398 1New York Giants to Host American Red Cross Blood Drive 56398 2
...ee of large-scale catastrophes to pursue their dre...epartment of Homeland Security (DHS) is the federa...errorist attacks and making it a more secure place...ough its Science & Technology (S&T) Directorate, w... leads to products, systems and services that help...
...etable oil and other renewable sources are increas...s as a way to reduce fossil fuel dependence and li... led by a biologist at the University of Washingto...rrent biofuel stocks might have exactly the opposi...ublished in the June issue of the journal Conserva...
...t a fundamental building block in the cells of flo...entically, on a separate branch of the evolutionar...s that originated at least 420 million years ago. ...ved from gymnosperms, the group that includes coni... from lycophytes hundreds of millions of years bef...
Other Biology News:DHS, business leaders discuss technology to protect US at Homeland Security conference 2DHS, business leaders discuss technology to protect US at Homeland Security conference 3Some biofuels might do more harm than good to the environment, study finds 2Some biofuels might do more harm than good to the environment, study finds 3When plants 'think' alike 2
(Date:11/5/2009)...hybrid . . . , Fuel economy ratings for the ne...e www.fueleconomy.gov web site, which Oak Ridge ...e U.S. Department of Energy and the U.S. Environme...s on the best fuel economy list are hybrid electri...ay). "This list proves that hybrids have gone main...
(Date:11/5/2009)... 5 DSM Pharmaceutical Products tod...ance with Galenix, Saint Jean D,Illac, France, whe...facturing partner for Galenix commercial products ...aborate on business development opportunities co-m... on the strength of Galenix in drug product develo...
(Date:11/5/2009)...rsday, November 5, 2009 at 4:30 p.m. Eastern Time ...e-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("O... reported unaudited financial results for the thir... and reviewed the Company,s highlights for the thi...ed results reflect the operations of OncoGenex Tec...
(Date:11/5/2009).... 5 Cepheid (Nasdaq: CP...peaking at the following investor conferences, and... Credit Suisse Healthcare Conferen...mber, 2009 at 10 a.m. Mountain Time, ...and, Tuesday, 1 December, 2009 at ...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2
...o and TEL AVIV, Israel, October 15 ,Simbionix USA ...of a Series,C round of growth capital financing le...nt investor Early Stage Partners and other existin...s who served as the,company,s investment bankers. ... the already rapid growth of its medical simulatio...
... Medical Education Agency Expanding Industry Conne...re,Communications LLC, an independent, full-servic...ring of Todd Weinstein as Vice President, Business...ence in medical education and,publishing as the he...he,served as Manager of Publication Sales at McMah...
..., Oct. 15 The increased emphasis on,safety by reg...medical,product development programs and requires ...ns by Sponsors to respond appropriately. Expertise...sulting organizations. GZP,has already emplaced sy...s,that can lead to adverse regulatory action by th...
Other Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 3
Mouse Anti-Human HLA Class II DQ1 7 Monoclonal Antibody, Unconjugated, Clone 4i144 from Abcam
Anti-ASCIZ Antibody, Unconjugated from CHEMICON
Goat Anti-CHMP5 Polyclonal Antibody, Unconjugated from Abcam
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: